2017 CHINA BIOPHARMACEUTICAL INDUSTRY REPORT 2017中国生物医药产业报告

2017 CHINA BIOPHARMACEUTICAL INDUSTRY REPORT

CIPHER GROUND

Date: October 2017
Pages: 30
Available in: English

China is the world’s second largest pharmaceutical market after the US and is expected to overtake the US by 2020. The biopharmaceutical industry is a thriving sector in China, forecasted to grow to about 15% of GDP in 2030, becoming an important economic growth point. China is moving from primarily a generic market to a global biopharmaceutical market.  At present, China has gathered all the three critical factors that will boost the innovation of China’s biopharmaceutical industry: "Right time, Right place, and Right people". On the road to innovation, however, China still has a lot of things to do, including:

  • Speeding up pharmaceutical policy reform
  • R & D internationalization
  • Development of cross-border technology intermediary
  • Accelerating therealization of the “Healthy China 2030” strategic

This report provides a complete and detailed analysis of the biopharmaceutical sector for China. Cipher Ground Insights, presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

Key Topics Covered:

  • The Rise of China’s Biopharmaceutical Industry
  • Challengesof China's Biopharmaceutical Industry
  • Unprecedented Strategic Height of the Biopharmaceutical Industry
  • Vast Opportunities in China's Biopharmaceutical Industry
  • High-Tech Development Zone - An Important Platform
  • Trillion-Dollar China Market
  • High-Tech Development Zone: Innovation Hub
  • Entrepreneurship of Overseas Talents Fuels Innovation
  • Increasing Values of Overseas Talents
  • Smart Investors Discover Talents
  • On the Road to Innovation
  • Cipher Opinion

Please contact us at info@cipherground.com for details!

Related Topics: Biopharmaceuticals

*The Chinese version of this report is available on request.